Cheng‐Hsu Wang

1.7k total citations
70 papers, 1.2k citations indexed

About

Cheng‐Hsu Wang is a scholar working on Oncology, Otorhinolaryngology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Cheng‐Hsu Wang has authored 70 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Oncology, 19 papers in Otorhinolaryngology and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Cheng‐Hsu Wang's work include Head and Neck Cancer Studies (19 papers), Nutrition and Health in Aging (9 papers) and Inflammatory Biomarkers in Disease Prognosis (7 papers). Cheng‐Hsu Wang is often cited by papers focused on Head and Neck Cancer Studies (19 papers), Nutrition and Health in Aging (9 papers) and Inflammatory Biomarkers in Disease Prognosis (7 papers). Cheng‐Hsu Wang collaborates with scholars based in Taiwan, United States and Malaysia. Cheng‐Hsu Wang's co-authors include Kun‐Yun Yeh, Jen‐Seng Huang, Pei‐Hung Chang, Jen‐Shi Chen, Wen‐Chi Chou, Chuang‐Chi Liaw, Siew Tzuh Tang, Yung‐Chang Lin, Eric Yen‐Chao Chen and Shih‐Wei Yang and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Cheng‐Hsu Wang

69 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cheng‐Hsu Wang Taiwan 20 519 244 242 208 199 70 1.2k
Freddi Lewin Sweden 16 340 0.7× 303 1.2× 463 1.9× 173 0.8× 289 1.5× 52 1.3k
Kun‐Yun Yeh Taiwan 24 777 1.5× 302 1.2× 228 0.9× 296 1.4× 253 1.3× 125 1.6k
Florence Guida France 19 354 0.7× 283 1.2× 132 0.5× 90 0.4× 102 0.5× 37 1.2k
Ronald J. Maggiore United States 21 532 1.0× 330 1.4× 121 0.5× 216 1.0× 149 0.7× 46 1.2k
Isao Oze Japan 27 920 1.8× 674 2.8× 267 1.1× 222 1.1× 604 3.0× 139 2.5k
Maryam Ebadi Canada 28 262 0.5× 159 0.7× 85 0.4× 1.1k 5.3× 318 1.6× 71 2.2k
Samir S. Khariwala United States 23 318 0.6× 298 1.2× 504 2.1× 209 1.0× 673 3.4× 79 1.6k
Marco Montella Italy 34 1.0k 2.0× 508 2.1× 81 0.3× 209 1.0× 387 1.9× 121 2.8k
I. Monteiro Grillo Portugal 16 732 1.4× 381 1.6× 372 1.5× 1.5k 7.3× 354 1.8× 36 2.3k

Countries citing papers authored by Cheng‐Hsu Wang

Since Specialization
Citations

This map shows the geographic impact of Cheng‐Hsu Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng‐Hsu Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng‐Hsu Wang more than expected).

Fields of papers citing papers by Cheng‐Hsu Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng‐Hsu Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng‐Hsu Wang. The network helps show where Cheng‐Hsu Wang may publish in the future.

Co-authorship network of co-authors of Cheng‐Hsu Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng‐Hsu Wang. A scholar is included among the top collaborators of Cheng‐Hsu Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng‐Hsu Wang. Cheng‐Hsu Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shen, Wen‐Chi, Shin‐Cheh Chen, Cheng‐Hsu Wang, et al.. (2024). Astragalus polysaccharides improve adjuvant chemotherapy-induced fatigue for patients with early breast cancer. Scientific Reports. 14(1). 25690–25690. 9 indexed citations
2.
Shen, Wen‐Chi, Ming‐Mo Hou, Tai‐Lin Huang, et al.. (2022). Transdermal buprenorphine improves overall quality of life and symptom severity in cancer patients with pain. Journal of Clinical Nursing. 32(3-4). 539–547. 2 indexed citations
3.
Liu, Chien-Ting, Yu‐Li Su, Cheng‐Hsu Wang, et al.. (2020). Sequential Circulating Tumor Cell Counts in Patients with Locally Advanced or Metastatic Hepatocellular Carcinoma: Monitoring the Treatment Response. Journal of Clinical Medicine. 9(1). 188–188. 19 indexed citations
4.
Chang, Pei‐Hung, et al.. (2020). Impact of Diabetes Mellitus on Head and Neck Cancer Patients Undergoing Concurrent Chemoradiotherapy. Scientific Reports. 10(1). 7702–7702. 9 indexed citations
5.
Lu, Hsueh‐Ju, Chih‐Cheng Hsieh, Yi‐Chen Yeh, et al.. (2019). Clinical, pathophysiologic, and genomic analysis of the outcomes of primary head and neck malignancy after pulmonary metastasectomy. Scientific Reports. 9(1). 12913–12913. 8 indexed citations
6.
Lin, Yu‐Ching, Shu‐Hang Ng, Yun‐Chung Cheung, et al.. (2018). Effect of Chemotherapy on Dual-Energy X-ray Absorptiometry (DXA) Body Composition Precision Error in Head and Neck Cancer Patients. Journal of Clinical Densitometry. 22(3). 437–443. 7 indexed citations
7.
Chang, Pei‐Hung, Cheng‐Hsu Wang, Eric Yen‐Chao Chen, et al.. (2017). Glasgow prognostic score after concurrent chemoradiotherapy is a prognostic factor in advanced head and neck cancer. Chinese Journal of Cancer Research. 29(3). 172–178. 9 indexed citations
8.
Wang, Cheng‐Hsu, et al.. (2015). Undertreatment of caner pain. Acta anaesthesiologica Taiwanica. 53(2). 58–61. 7 indexed citations
9.
Wang, Hung‐Ming, Hsien‐Kun Chang, Chia‐Hsun Hsieh, et al.. (2013). Cisplatin, tegafur-uracil and leucovorin plus mitomycin C: an acceptably effective and toxic regimen for patients with recurrent or metastatic nasopharyngeal carcinoma. Biomedical Journal. 36(5). 229–229. 10 indexed citations
10.
Chang, Pei‐Hung, et al.. (2013). Competing Causes of Death in Patients with Oral Cavity Cancer in a Single Cancer Center in Taiwan. 29(1). 14–21. 1 indexed citations
11.
Bauer, Brent A., Simon Hsia, Cheng‐Hsu Wang, et al.. (2013). Reduction of Splenic Immunosuppressive Cells and Enhancement of Anti-Tumor Immunity by Synergy of Fish Oil and Selenium Yeast. PLoS ONE. 8(1). e52912–e52912. 28 indexed citations
12.
Yeh, Kun‐Yun, Hung‐Ming Wang, John W. C. Chang, et al.. (2013). Omega-3 fatty acid-, micronutrient-, and probiotic-enriched nutrition helps body weight stabilization in head and neck cancer cachexia. Oral Surgery Oral Medicine Oral Pathology and Oral Radiology. 116(1). 41–48. 54 indexed citations
13.
Chang, Pei‐Hung, Cheng‐Hsu Wang, Jen‐Seng Huang, et al.. (2012). Low body mass index at 3 months following adjuvant chemoradiation affects survival of postoperative locally advanced oral cavity cancer patients. The Laryngoscope. 122(10). 2193–2198. 16 indexed citations
14.
Chang, Pei‐Hung, et al.. (2011). Hypersensitivity Reaction to Oxaliplatin. 27(5). 222–226. 1 indexed citations
15.
Chang, John Wen‐Cheng, Jia‐Juan Hsieh, Kun‐Yun Yeh, et al.. (2009). Bisphosphonate zoledronic acid enhances the inhibitory effects of gefitinib on EGFR-mutated non-small cell lung carcinoma cells. Cancer Letters. 278(1). 17–26. 23 indexed citations
16.
Lee, Sai-Cheong, Kuo-Su Chen, Ching-Chang Lee, et al.. (2004). An Outbreak of Methicillin-Resistant Staphylococcus aureus Infections Related to Central Venous Catheters for Hemodialysis. Infection Control and Hospital Epidemiology. 25(8). 678–684. 13 indexed citations
17.
Wang, Cheng‐Hsu, et al.. (2004). Hypercalcemia in Prostate Cancer with Positive Neuron‐Specific Enolase Stain. Renal Failure. 26(3). 325–327. 5 indexed citations
18.
Yeow, Kee‐Min, Cheng‐Hsu Wang, Jen‐Shi Chen, et al.. (1999). The Groshong Peripheral Inserted Central (PIC) Catheter: Initial Experience with Ultrasound-guided Insertion. 24(2). 61–66. 1 indexed citations
19.
20.
Wang, Cheng‐Hsu & Robert Schilling. (1995). Myocardial infarction and thalassemia trait: An example of heterozygote advantage. American Journal of Hematology. 49(1). 73–75. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Freddi Lewin Breakdown of academic impact, for papers by Kun‐Yun Yeh Breakdown of academic impact, for papers by Florence Guida Breakdown of academic impact, for papers by Ronald J. Maggiore Breakdown of academic impact, for papers by Isao Oze Breakdown of academic impact, for papers by Maryam Ebadi Breakdown of academic impact, for papers by Samir S. Khariwala Breakdown of academic impact, for papers by Marco Montella Breakdown of academic impact, for papers by I. Monteiro Grillo
Rankless by CCL
2026